Skip to content

A study of the efficacy of digital behavioral activation therapy on anhedonia symptoms of adolescent depression

A study of the efficacy of digital behavioral activation therapy on anhedonia symptoms of adolescent depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106290
Enrollment
Unknown
Registered
2025-07-22
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent depression

Interventions

Digital Behavioural Activation Therapy Treatment Group:Digital Behavioural Activation Therapy
Digital Behavioural Activation Therapy Waiting Group:Nothing

Sponsors

Peking University Sixth Hospital ( Institute of Mental Health )
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 19 Years

Inclusion criteria

Inclusion criteria: 1. Age 12~19 years old, male or female; 2. Meet the DSM-5 diagnostic criteria for depressive disorder; 3. A2 items of the MIINIkid scale (presence or absence of symptoms of decreased interest and loss of pleasure) are assessed as "yes" and the total score of the Snaith-Hamilton Pleasure Scale (SHAPS) is >= 3 points (two-point scoring). 4. No electroconvulsive therapy or rTMS therapy in the past 6 months; Current medication regimen has been stable for at least 6 weeks. 5. Have certain literacy and comprehension skills; 6. No other serious neurological and/or physical diseases at present or in the past; No history of epilepsy; 7. No current serious suicide risk (MINIKid current suicide risk <=17 points); 8. Informed consent of the patient and his guardian.

Exclusion criteria

Exclusion criteria: 1. Inability to complete questionnaires and psychological assessments independently; 2. Obvious cognitive impairment judged by systematic psychiatric examination, unable to sign the informed consent form; 3. Suffering from major physical diseases, such as cardiovascular and cerebrovascular diseases, respiratory diseases, liver and kidney diseases, malignant tumors, etc.; 4. Receiving other psychotherapy 5. Participating in other studies. 6. Neither parent is willing to participate in the entire intervention treatment process.

Design outcomes

Primary

MeasureTime frame
Anhedonia symptoms;

Secondary

MeasureTime frame
Depressive symptoms;

Countries

China

Contacts

Public ContactSu Yunai

Peking University Sixth Hospital ( Institute of Mental Health )

suyunai@163.com+86 10 62723767

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026